Lung Cancer Europe
@LungCancerEu
LuCE is the voice of people affected by lung cancer in Europe, advocating and networking to improve outcomes for the community. #LungCancer #LCSM
ID:811532090655260672
http://www.lungcancereurope.eu/ 21-12-2016 11:21:42
1,9K Tweet
1,8K Takipçi
575 Takip Edilen
A reminder that the first of the sessions hosted by Oncogene Cancer Research focusing on patient advocacy is on this evening.
Chaired by LuCE member Yvonne Diaz of Oncogene Cancer Research, it will bring together those forging paths into advocacy.
More: oncogeneresearch.org/patient-advoca…
🔵🫁 Si eres #paciente de #cáncerdepulmón o si alguna persona de tu alrededor padece la enfermedad👇
➡️ Desde Cáncer de Pulmón te animamos a responder esta encuesta
👉 Iniciativa de Lung Cancer Europe con el apoyo de Cáncer de Pulmón y Fundación MÁS QUE IDEAS
➡️ surveymonkey.com/r/LuCESurvey20…
🎗️Cancer is a major public health concern in Europe. Widespread screening and early diagnosis together with comprehensive prevention policies are needed to help eradicate it. EU One Health and OECD ➡️ Better Policies for Better Lives explain: europa.eu/!gRVcHp
European Week Against Cancer #EUCancerPlan #EWAC2024
Lung diseases are one of the biggest killers.
With more than 40 conditions, #respiratory diseases are debilitating, affecting lives and the economy, and leading to comorbidities.
How can the EU ensure its citizens can #KeepBreathing ➡️bit.ly/3SMMa4x #Vote4Patients
@LungCancerEU is de Europese koepel van patiëntenorganisaties voor longkanker. Elk jaar zet LuCE een vragenlijst uit. Wij werken daaraan mee voor Nederland.
Ben je patiënt of naaste? Je kunt hier de vragenlijst invullen cutt.ly/keyFU2QU
#9LuCEReport #longkanker
🔵🫁Desde Cáncer de Pulmón queremos agradecer a
🔹 Irene Sansano, MD Phd, patóloga molecular SEAP-IAP
🔹Ivana Sullivan, MD, PhD, oncóloga médica Grupo Español de Cáncer de Pulmón
haber compartido sus conocimientos sobre la medicina de precisión
➡️ También dar las gracias a Fundación MÁS QUE IDEAS y a From Testing to Targeted Treatments (FT3) por hacerlo posible
Yes you did read this correctly 😉 We have a limited number of places for #lungcancer nurses at this years conference. Where else would you get the opportunity to hear from such a distinguished list of ALK+ experts at the same event?
Secure your spot today by emailing
Lung cancer is the biggest cause of cancer deaths in Aotearoa New Zealand. It also disproportionately affects Indigenous Māori communities. Read our latest case study to discover how they have worked to develop a Māori-led screening programme. #LCSM lungcancerpolicynetwork.com/lung-cancer-sc…
Today is the last day to apply for the European Society for Medical Oncology travel grants to support patient advocates attending the #ESMOCongress 2024 Patient Advocacy Track in #Barcelona from September 13th to 17th, 2024.
More information here: esmo.org/meeting-calend…
It is vital that lung cancer screening programmes are set up to be effective, equitable and sustainable. Our policy briefs are now available in Arabic, French Simplified Chinese and Spanish to support those seeking to implement lung cancer screening. #LCSM lungcancerpolicynetwork.com/policy-briefs-…
Lung Cancer Europe announces the launch of an important new survey
Lung Cancer Europe
oncodaily.com/insight/71403.…
#Cancer #LCSM #Survey #OncoDaily #Oncology
Join us for the 2nd webinar in the #ReduceCancerInequalities series during #EWAC2024 !
Day 2 will explore barriers to #innovativediagnostics and #accuratediagnosis building on the latest IHESweden report!
Register ➡ shorturl.at/RivoJ
#EUCancerPlan #CloseTheCareGap
Is shared decision making a reality or still an NHS phrase for #lungcancer patients in the UK?
People & caregivers impacted are invited to complete this short, anonymous survey from Lung Cancer Europe.
Takes only 10-15 mins. 👉de.surveymonkey.com/r/LuCESurvey20…
Whether you’re a patient considering advocacy or already a seasoned pro, don't miss this Zoom discussion on May 29 at 6pm CET.
Hosted by LuCE member @Yvonne_Diaz_LC of Oncogene Cancer Research, this aims to inform, inspire and connect on advocacy.
oncogeneresearch.org/patient-advoca…
To what extent are those impacted by #lungcancer in Europe involved in shared decision making?
People & caregivers impacted are invited to complete this short, anonymous survey from Lung Cancer Europe.
Takes only 10-15 mins. 👉de.surveymonkey.com/r/LuCESurvey20…
#lcsm #Patient #Advocacy
